BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 36980799)

  • 1. Implication of Obesity and Gut Microbiome Dysbiosis in the Etiology of Colorectal Cancer.
    Singh S; Sharma P; Sarma DK; Kumawat M; Tiwari R; Verma V; Nagpal R; Kumar M
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
    Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
    Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of dysbiotic human gut microbiome for homeostasis.
    Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
    Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.
    Cuevas-Sierra A; Ramos-Lopez O; Riezu-Boj JI; Milagro FI; Martinez JA
    Adv Nutr; 2019 Jan; 10(suppl_1):S17-S30. PubMed ID: 30721960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing Colorectal Cancer through Prebiotics.
    Mahdavi M; Laforest-Lapointe I; Massé E
    Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34207094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics, prebiotics and colorectal cancer prevention.
    Ambalam P; Raman M; Purama RK; Doble M
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development.
    Genua F; Raghunathan V; Jenab M; Gallagher WM; Hughes DJ
    Front Oncol; 2021; 11():626349. PubMed ID: 33937029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spot-light on microbiota in obesity and cancer.
    Marzullo P; Bettini S; Menafra D; Aprano S; Muscogiuri G; Barrea L; Savastano S; Colao A;
    Int J Obes (Lond); 2021 Nov; 45(11):2291-2299. PubMed ID: 34363002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy.
    Kvakova M; Kamlarova A; Stofilova J; Benetinova V; Bertkova I
    World J Gastroenterol; 2022 Jul; 28(27):3370-3382. PubMed ID: 36158273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review).
    Kumavath R; Pavithran H; Paul S; Anju VT; Busi S; Dyavaiah M
    Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 37997816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the Role of Gut Microbiome in Colon Cancer.
    Chattopadhyay I; Dhar R; Pethusamy K; Seethy A; Srivastava T; Sah R; Sharma J; Karmakar S
    Appl Biochem Biotechnol; 2021 Jun; 193(6):1780-1799. PubMed ID: 33492552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiome Changes in Gestational Diabetes.
    Ionescu RF; Enache RM; Cretoiu SM; Gaspar BS
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Insights Into the Interactions Between the Gut Microbiome, Inflammasomes, and Gasdermins During Colorectal Cancer.
    Privitera G; Rana N; Scaldaferri F; Armuzzi A; Pizarro TT
    Front Cell Infect Microbiol; 2021; 11():806680. PubMed ID: 35111698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
    Kang Y; Pan W; Cai Y
    Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome in tumorigenesis and therapy of colorectal cancer.
    Wang L; Yu KC; Hou YQ; Guo M; Yao F; Chen ZX
    J Cell Physiol; 2023 Jan; 238(1):94-108. PubMed ID: 36409765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota-Adversary or Ally? Its Role and Significance in Colorectal Cancer Pathogenesis, Progression, and Treatment.
    Chawrylak K; Leśniewska M; Mielniczek K; Sędłak K; Pelc Z; Pawlik TM; Polkowski WP; Rawicz-Pruszyński K
    Cancers (Basel); 2024 Jun; 16(12):. PubMed ID: 38927941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of gut microbes and its metabolites in colorectal cancer.
    Kumar A; Ali A; Kapardar RK; Dar GM; Nimisha ; Apurva ; Sharma AK; Verma R; Sattar RSA; Ahmad E; Mahajan B; Saluja SS
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):441-465. PubMed ID: 36572792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.